SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-033169
Filing Date
2022-09-13
Accepted
2022-09-13 16:05:45
Documents
4
Period of Report
2022-10-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20005123x2_def14a.htm DEF 14A 251025
2 ny20005123x2-pc_1.jpg GRAPHIC 537140
3 ny20005123x2-pc_2.jpg GRAPHIC 355363
4 sig_ganirvan.jpg GRAPHIC 17911
  Complete submission text file 0001140361-22-033169.txt   1505233
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38470 | Film No.: 221240804
SIC: 2834 Pharmaceutical Preparations